A study by the MD Anderson group evaluated the outcomes of 573 patients treated at the institute. Oropharynx (33.3%; n = 191), paranasal sinus (11%; n = 63)...

A review examined a total of 26 original studies (15 protons, 10 carbon ions, and 1 helium/neon studies) involving a total of 1,118 patients (437 with protons...

In select clinical scenarios of well-lateralized tumors, radiotherapy can be delivered to the primary tumor or tumor bed and the ipsilateral nodal regions. This...

This guideline reviews examined proton therapy for nasopharynx, reirradiation, sinonasal, postoperative and oropharynx and made recommendations. Proton therapy...

This is a retrospective analysis of 16 patients who received PBRT reRT for recurrent meningiomas. The median PBRT dose was 60 Gy(RBE) and the median follow-up...

Sixty-nine patients with sinonasal tumors underwent curative intent PBT including 42 patients received de novo irradiation and 27 received reirradiation. With...

A systematic review assessing for reports of proton-beam reirradiation for recurrent or second primary GI cancers. 7 included studies reported on proton-beam re...

A review article looked at the development of RT advances. There is a growing awareness of the potential clinical benefits of proton therapy over IMRT in the...

A general review on PBT inlcuding dosimetric advantage, clinical data on PBT for ocular tumor, skull base, paraspinal tumors (chondrosarcoma and chordoma), and...

Published in the Lancet Oncology, this review article summarized the recent published outcomes of proton therapy head and neck cancer.

In reviewing PT for...